122 related articles for article (PubMed ID: 1832087)
1. Cytolytic activities of activated macrophages versus paraformaldehyde-fixed macrophages; soluble versus membrane-associated TNF.
Fishman M
Cell Immunol; 1991 Oct; 137(1):164-74. PubMed ID: 1832087
[TBL] [Abstract][Full Text] [Related]
2. TPA induction of EL4 resistance to macrophage-released TNF: role of ADP-ribosylation in tumoricidal activities of TNF and other factors.
Fishman M; Essani N; Costlow M
Cell Immunol; 1990 Apr; 127(1):78-91. PubMed ID: 2138520
[TBL] [Abstract][Full Text] [Related]
3. Differences in the tumor necrosis factor-alpha-mediated lysis by fixed natural cytotoxic cells and fixed cytotoxic macrophages.
Vanderslice WE; Collins JL
J Immunol; 1991 Jan; 146(1):156-61. PubMed ID: 1984442
[TBL] [Abstract][Full Text] [Related]
4. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells.
Remels L; Fransen L; Huygen K; De Baetselier P
J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350
[TBL] [Abstract][Full Text] [Related]
5. TNF induction of EL4 hyposensitivity to lysis by recombinant (soluble) and membrane-associated TNFs: TNF binding, internalization, and degradation.
Fishman M; Costlow M
Cell Immunol; 1994 Apr; 154(1):453-67. PubMed ID: 8131213
[TBL] [Abstract][Full Text] [Related]
6. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
[TBL] [Abstract][Full Text] [Related]
7. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
Ichinose Y; Bakouche O; Tsao JY; Fidler IJ
J Immunol; 1988 Jul; 141(2):512-8. PubMed ID: 3260254
[TBL] [Abstract][Full Text] [Related]
9. Leukemic cell lysis by activated human macrophages: significance of membrane-associated tumor necrosis factor.
Nakabo Y; Harakawa N; Yamamoto K; Okuma M; Uno K; Sasada M
Jpn J Cancer Res; 1993 Nov; 84(11):1174-80. PubMed ID: 8276722
[TBL] [Abstract][Full Text] [Related]
10. Cytolysis of adenovirus-infected murine fibroblasts by IFN-gamma-primed macrophages is TNF- and contact-dependent.
Day DB; Zachariades NA; Gooding LR
Cell Immunol; 1994 Aug; 157(1):223-38. PubMed ID: 8039246
[TBL] [Abstract][Full Text] [Related]
11. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
Levesque MC; Haynes BF
J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292
[TBL] [Abstract][Full Text] [Related]
12. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
Nii A; Fidler IJ
Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of leukemic cell lysis by activated human macrophages: leukemic cells can be lysed without direct contact.
Nakabo Y; Harakawa N; Yamamoto K; Okuma M; Uno K; Sasada M
Int J Hematol; 1994 Jul; 60(1):51-7. PubMed ID: 7919238
[TBL] [Abstract][Full Text] [Related]
14. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
15. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
[TBL] [Abstract][Full Text] [Related]
16. Study of the dependence of human monocytes and macrophages antitumoral properties upon TNF-alpha expression or release.
Dumont S; Mabondzo A; Hartmann D; Gilgenkrantz JL; Kessler R; Poindron P; Bartholeyns J
Anticancer Res; 1990; 10(4):949-54. PubMed ID: 2116753
[TBL] [Abstract][Full Text] [Related]
17. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages.
Decker T; Lohmann-Matthes ML; Gifford GE
J Immunol; 1987 Feb; 138(3):957-62. PubMed ID: 3492537
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
20. IL-2. A cofactor for induction of activated macrophage resistance to infection.
Belosevic M; Finbloom DS; Meltzer MS; Nacy CA
J Immunol; 1990 Aug; 145(3):831-9. PubMed ID: 2115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
